Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
Survivin is expressed in prostate cancer (PCa), and its downregulation sensitizes PCa cells to chemotherapeutic agents in vitro and in vivo. Small membrane-bound vesicles called exosomes, secreted from the endosomal membrane compartment, contain RNA and protein that they readily transport via exosom...
Main Authors: | Salma Khan, Jessica M S Jutzy, Malyn May A Valenzuela, David Turay, Jonathan R Aspe, Arjun Ashok, Saied Mirshahidi, Dan Mercola, Michael B Lilly, Nathan R Wall |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3473028?pdf=render |
Similar Items
-
Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients.
by: Salma Khan, et al.
Published: (2017-01-01) -
Localization and upregulation of survivin in cancer health disparities: a clinical perspective
by: Khan S, et al.
Published: (2015-07-01) -
Natural Killer Cell Phenotype and Functionality Affected by Exposure to Extracellular Survivin and Lymphoma-Derived Exosomes
by: Heather R. Ferguson Bennit, et al.
Published: (2021-01-01) -
Survivin: A molecular biomarker in cancer
by: Praveen Kumar Jaiswal, et al.
Published: (2015-01-01) -
The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance
by: Bridget T. Kreger, et al.
Published: (2016-12-01)